Investments News

Mindera Raises Over $12 Million Series A-2 Financing

Mindera Raises Over $12 Million Series A-2 Financing

Mindera Corporation  announced a $12.6M Series A-2 capital raise.The round was led by Mountain Group Partners, Rockmont Investments, and Scientific Health Development. The funding will be used to commercialize Mind.Px, a groundbreaking tool to prospectively predict patient response to expensive psoriasis biologics, as well as continue development of the Mindera Dermal Intelligence Platform.

Read More: Broadridge Completes Acquisition of Itiviti, Extending Capital Markets Franchise

The Mindera platform uses a simple patch that extracts biomarkers from the skin in minutes, allowing for rapid and painless extraction of RNA. Subsequent Next-Generation Sequencing of the extracted RNA allows Mindera scientists to take a genetic and transcriptomic snapshot of the skin at the exact moment of the test. In the case of Mind.Px, this rich patient-specific data is then analyzed by proprietary machine learning algorithms to predict the appropriate psoriasis biologic drug for a patient prior to therapeutic selection and treatment.

Read More: CloudWalk Announces US$190 Million Series B Financing Round Led by Coatue

Mind.Px is a first-of-its-kind precision medicine dermatology solution that aligns patient, physician, and payer interests by predicting effective biologics for individuals, avoiding trial-and-error prescription behavior and wasted payer spending.

Read More: CloudCard, Inc. Selects Arroweye Solutions as Card Fulfillment Partner

Related posts

Sologenic (SOLO) Trading Goes Live on CoinField

Fintech News Desk

Teranet Inc. Partners With Morningstar Sustainalytics to Offer Climate Risk Intelligence Solutions to Customers

Fintech News Desk

BNK BUSAN BANK Selects Seculetter’s Security Solution to Block APT Attacks

Fintech News Desk
1